SCHEMBL27727914

SCHEMBL27727914

[CH2]C[C@H](c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1)c1ccccc1C(C)(C)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYSLTR2 Q9NS75 3/20 0.55
▸ CYSLTR1 Q9Y271 3/20 0.55
▸ CYP2C8 P10632 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ RECQL P46063 1/20 0.55
▸ BLM P54132 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ ABCB11 O95342 1/20 0.55
▸ EGFR P00533 1/20 0.55
▸ ESR1 P03372 1/20 0.55
▸ NR3C1 P04150 1/20 0.55
▸ FYN P06241 1/20 0.55
▸ PGR P06401 1/20 0.55
▸ ADRB2 P07550 1/20 0.55
▸ ADRB1 P08588 1/20 0.55
▸ ADRA2A P08913 1/20 0.55
▸ ADORA3 P0DMS8 1/20 0.55
▸ CHRM1 P11229 1/20 0.55
▸ ADRB3 P13945 1/20 0.55
▸ ADRA2B P18089 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27600259 1.00 CYSLTR2 (0.55) CYSLTR2CYSLTR1CYP2C8MEN1RECQL
SCHEMBL27318096 1.00 CYSLTR2 (0.55) CYSLTR2CYSLTR1CYP2C8MEN1RECQL
SCHEMBL3125908 0.90 CYSLTR2 (0.56) CYSLTR2CYSLTR1CYP2C8MEN1RECQL
SCHEMBL3132243 0.90 CYSLTR2 (0.56) CYSLTR2CYSLTR1CYP2C8MEN1RECQL
SCHEMBL2793767 0.90 CYSLTR2 (0.56) CYSLTR2CYSLTR1CYP2C8MEN1RECQL
SCHEMBL3131403 0.90 CYSLTR2 (0.56) CYSLTR2CYSLTR1CYP2C8MEN1RECQL
SCHEMBL3028209 0.90 CYSLTR2 (0.56) CYSLTR2CYSLTR1CYP2C8MEN1RECQL
SCHEMBL3355559 0.86 CYSLTR1 (0.53) CYSLTR2CYSLTR1CYP2C8MEN1RECQL
SCHEMBL2569565 0.85 CYSLTR2 (0.53) CYSLTR2CYSLTR1CYP2C8MEN1RECQL
SCHEMBL27763757 0.84 CYP2C8 (0.59) CYSLTR2CYSLTR1CYP2C8MEN1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102164897-B Method for preparing montelukast sodium salts LG LIFE SCIENCES LTD 2013-04-17 — — CN disclosed
CN-102164897-A Method for preparing montelukast sodium salts LG LIFE SCIENCES LTD 2011-08-24 — — CN disclosed
CN-101213177-A Purification of montelukast TEVA PHARMA (IL) 2008-07-02 — — CN disclosed
Send feedback